Table 3.
No | Author & years of publication | Surgical Intervention | NLR (mean ± SD) | NLR Cut-off | Cut-off point calculation | Median OS | Median CSS | Primary Outcome | Secondary Outcome |
---|---|---|---|---|---|---|---|---|---|
1 | Kasuga et al., 2016 | Radical Penectomy | 5.03 ± 4.99 | 2.82 | AUC | NR | NR | OS, CSS | LNM |
2 | Tan et al., 2017 | Bilateral modified inguinal lymph node dissection or dynamic sentinel node biopsy | 2.99 (0.76–5.22)∗∗ | 2.8 | AUC | NR | NR | CSS, PFS, | LNM |
3 | Azizi et al., 2018 | Bilateral/unilateral inguinal lymph node dissection | 4.51 ± 3.95 | 3 | Contal and O'Quigley method | 89 (31.2–123.6) months∗∗ | NR | OS, CSS, RFS | LNM |
4 | Li et al., 2019 | Bilateral inguinal lymph node dissection | 2.4 (0.1–44.2)∗ | 2.6 | ROC | NR | NR | CSS | LNM |
5 | Jiao Hu et al., 2020 | Bilateral inguinal lymph node dissection after primary tumor procedure | NR | 3.59 | ROC | NR | NR | CSS | LNM |
6 | Chen Hu et al., 2020 | Inguinal lymph node dissection | NR | 2.94 | AUC | 34 (18–84) months∗∗ | 33 (18–85.25) months∗∗ | OS, PFS | LNM |
7 | Jindal et al., 2021 | Penectomy with bilateral inguinal node dissection | NR | 3 | Following previous study by Azizi et al. | NR | 18 (2–74) months∗ | CSS | LNM |
NLR = Neutrophil-lymphocyte ratio, ROC = Receiver operating characteristic curve, AUC = Area under the curve, OS = Overall Survival, CSS = Cancer specific-survival, PFS = Progression-free survival, LNM = Lymph-Node Metastasis.
Data expressed as median and range.
Data expressed as median and interquartile (IQR) range.